Denis Katz MD

יצר מאמר חדש

3 ב

Precision Neurology 2026 From Syndromes to Signatures: The Strategic Rewiring of CNS Drug Development | #denis Katz medical affairs

Precision Neurology 2026 From Syndromes to Signatures: The Strategic Rewiring of CNS Drug Development

From syndromes to signatures: how precision biomarkers and regulatory strategy are rewiring CNS drug development and reducing late-stage failure.

כמו

תגובה

לַחֲלוֹק

שינה את תמונת הפרופיל שלו

3 ב

כמו

תגובה

לַחֲלוֹק

טען עוד פוסטים

זָכָר
פוסטים 2

08/21/90
גר ב United States
ממוקם ב United States
https://salienceclinical.com/

על אודות

AAV-mediated delivery of enzymes, neurotransmitter-modulating proteins, or neurotrophic factors has been extensively explored in Parkinson’s disease. While early studies suggested biological activity, several randomized controlled trials failed to meet primary clinical endpoints, highlighting the challenges of placebo effects, target engagement, and disease heterogeneity.

אלבומים

(0)

חברים

(0)

אוהב

(0)

קבוצות

(0)

3 ב

Precision Neurology 2026 From Syndromes to Signatures: The Strategic Rewiring of CNS Drug Development

3 ב

שפה